Intervention

MSCs

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions7

Lead sponsors shown4

Clinical trials

4 shown

Mesenchymal Stem Cells for Chronic Kidney DiseasesNCT07240987 · 2026-01-01

NOT_YET_RECRUITING

Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple SclerosisNCT04749667 · 2021-08-09

ACTIVE_NOT_RECRUITING

Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2NCT02943486 · 2017-01-01

MSC Administration for the Management of Type 1 Diabetic PatientsNCT02893306 · 2012-03-01

Common conditions

Diabetic Kidney Disease (DKD)1 Foot Ulcer, Diabetic1 Hypertensive Nephropathy1 Kidney Disease, Chronic1 Multiple Sclerosis1 Progressive Multiple Sclerosis1 Type 1 Diabetes Mellitus1

Leading sponsors

Haukeland University Hospital1 The First Affiliated Hospital of Air Force Medicial University1 Universidad Autónoma de Bucaramanga1 Universidad del Desarrollo1

Trial status mix

UNKNOWN2

ACTIVE_NOT_RECRUITING1

NOT_YET_RECRUITING1

Phase mix

PHASE24

PHASE13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.